Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery

October 16, 2013 updated by: Sulman Rafiq, Rigshospitalet, Denmark

Multimodal Opiate-sparing Analgesia Versus Traditional Opiate Based Analgesia After Cardiac Surgery, a Randomized Controlled Trial

To test if multimodal analgesia with different analgesic medication offer better pain relief, lesser side effects and is safe compared to conventionel opiod analgesia after cardiac surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Rigshospitalet, Copenhagen University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age>18
  • any cardiac procedure with sternotomy
  • able to give informed consent

Exclusion Criteria:

  • cardiac surgery without sternotomy
  • peripheral neuropathy
  • neurological disease
  • psychiatric illness
  • history of GI bleeding
  • chronic pain (i.e. back pain, cancer, arthritis)
  • serum creatinine >150 μmol/l
  • hepatic disease with elevated liver enzymes (SGPT and SGOT elevated to 1.5 times maximum normal value)
  • allergic to study medication
  • alcohol abuse
  • abuse of narcotics or medication
  • pregnancy
  • participation in other clinical trials
  • insufficient language skills
  • In addition intensive care unit (ICU) stay for more than 24 hours was used as a pre-defined post randomization exclusion criteria, because prolonged ICU stay and ventilator treatment would interfere with study analgesic protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multimodal
oral Ibuprofen 400mg 4 times daily oral Gabapentin 300mg twice daily oral Paracetamol 1000mg 4 times daily
oral ibuprofen 400mg 4 times daily
Other Names:
  • non-selective Non-steroid antiinflammatory drug (NSAID)
Oral Gabapentin 300mg twice daily
oral paracetamol 1000mg four times daily
Active Comparator: Morphine
oral Morphine 10mg 4 times daily oral paracetamol 1000mg 4 times daily
oral paracetamol 1000mg four times daily
10 mg morphine orally 4 times daily
Other Names:
  • An opiod

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of analgesic effect by 11-NRS scale
Time Frame: 4th postoperative day
assessement of analgesic effect for the first 4 days after surgery
4th postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Additional analgesic consumption
Time Frame: 4th postoperative day
4th postoperative day
Hospital stay in days.
Time Frame: days until discharge
days until discharge
Evaluation of side-effects by daily questionnaire
Time Frame: 4th postoperative day
4th postoperative day
Cardiac complications
Time Frame: 30th postoperative day
i.e. Myocardial infarction(MI), postoperative pericardial effusion, heart failure requiring inotropic support , atrial fibrillation.
30th postoperative day
Other complications
Time Frame: 30th postoperative day
i.e. cerebral (stroke, bleeding), GI(bleeding), blood component requirements and sternal complications.
30th postoperative day
30 day Mortality
Time Frame: 30th postoperative day
Death from all causes.
30th postoperative day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Skov Olsen, MD,PhD,DMSc, Rigshospitalet, Denmark
  • Study Chair: Sulman Rafiq, MD, Rigshospitalet, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2007

Primary Completion (Actual)

August 1, 2009

Study Completion (Actual)

December 1, 2009

Study Registration Dates

First Submitted

September 30, 2013

First Submitted That Met QC Criteria

October 16, 2013

First Posted (Estimate)

October 21, 2013

Study Record Updates

Last Update Posted (Estimate)

October 21, 2013

Last Update Submitted That Met QC Criteria

October 16, 2013

Last Verified

October 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Ibuprofen

Subscribe